Your session is about to expire
← Back to Search
Microbiota Therapy with Acetate for Depression and Anxiety
Study Summary
This trial will study the feasibility of using acetate to encourage the growth of Akkermansia muciniphila in order to mitigate weight gain and metabolic abnormalities caused by psychiatric medications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What objectives are investigators hoping to accomplish with this research?
"Over a period of 5 months, the primary outcome in this study is measuring retention. Secondary outcomes involve assessing patient depression using Quick Inventory of Depressive Symptomatology (QIDS-SR), anxiety levels with Overall Anxiety Severity and Impairment Scale (OASIS) as well as tracking blood pressure via medical-grade arm cuff."
Who is eligible to partake in this research initiative?
"This investigation is accepting 10 adolescent patients suffering from depression. To be admissible, all of the following conditions must be met: 'Yes' responses to each inclusion criteria, signed informed consent prior to any trial-related activities, between 16 and 28 years old and registered with FEMAP, a stable dose of antidepressant/mood stabilizer/antipsychotic drugs plus recent (approx 5%) weight gain linked temporally with initiating said drug as confirmed by psychiatrist, BMI ≥ 21.7 kg/m2 (midpoint normal range)."
Is there any risk associated with the ingestion of Acetate (Apple Cider Vinegar)?
"Acetate (Apple Cider Vinegar) safety is still being tested, thus receiving a score of 1 on our team's scale. This Phase 1 trial has limited evidence in regards to its efficacy and safety."
Is the upper age limit for participation in this study more than 75 years?
"The study is looking for candidates within the age range of 16 to 25 years old."
Is the patient recruitment phase of this trial still underway?
"According to information hosted on clinicaltrials.gov, this medical trial is no longer enrolling participants as it was last updated on August 29th 2022. However, there are 1169 other trials taking part in the recruitment of patients at present."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger